With the analysis among 70 patents, we discovered top 13 key players by total patent application. Swedish Orphan Biovitrum AB, Amgen, Inc., Warner-Lambert Co. are dominant in this area. They take 62.86% of the total patent filing.
Swedish Orphan Biovitrum AB
California, United States
Patent: 6
New Jersey, United States
Patent: 6
New York, United States
Patent: 4
Tibet Rhodiola Pharmaceutical Holding Co.
Xizang Zizhiqu, China
Patent: 2
Delaware, United States
Patent: 1
New Jersey, United States
Patent: 1
ARIAD Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
No data, please try another search term
With the analysis among related 26 patents applied in the last 5 years. We discover 10 most active companies in this area. The fast-growing Swedish Orphan Biovitrum AB, Wayne State University Board of Governors, SelectImmune Pharma AB take 30.77% of patent filing during this period.
Swedish Orphan Biovitrum AB
Wayne State University Board of Governors
Cedars-Sinai Medical Center
California, United States
Patent: 2
ZURICH, Switzerland
Patent: 1
New Jersey, United States
Patent: 1
Delaware, United States
Patent: 1
Basel-Stadt, Switzerland
Patent: 1
With the analysis among related 26 patents in last 5 years, we discover 8 new entrants. SelectImmune Pharma AB, Cedars-Sinai Medical Center, University of Zurich are the most active new entrants in this area.
Cedars-Sinai Medical Center
California, United States
Patent: 2
ZURICH, Switzerland
Patent: 1
New Jersey, United States
Patent: 1
Delaware, United States
Patent: 1
Basel-Stadt, Switzerland
Patent: 1
With the analysis among 14 patents, we discovered top 4 universities and scientific research institutions by total patent application. University of Basel, Centre Hospitalier Universitaire de Rouen, Université de Rouen Normandie are dominant in this area. They take 78.57% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 1
Centre Hospitalier Universitaire de Rouen
Université de Rouen Normandie
ZURICH, Switzerland
Patent: 1